In this study, we evaluated the physiological and molecular functions and regulation of EZH2 in NASH pathogenesis, showing that treatment of EZH2 inhibitors EPZ6438, UNC1999 in an in vivo model of STAM NASH mice. The gene discussed is EZH2; the disease is metabolic dysfunction-associated steatohepatitis.